UK teams up with Singapore on healthtech regulation
A first-of-its-kind partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Singaporean Health Sciences Authority (HSA) say the ‘regulatory innovation corridor’ aims to speed up patient access to breakthrough therapies in high-impact…